Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

A session of the American College of Obstetricians and Gynecologists 2021 annual meeting pointed to the dramatic increase in sexually transmitted infections (STIs) in the United States and presented ...

As RSV prevention tools expanded, clinicians faced new decisions around allocation, coordination, and outreach. In the final installment of this 3-part HCP Live Network RX Review roundtable, moderator ...

In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education. As the field of RSV prevention continues to grow, pediatricians face both new ...

Rizzo is joined by 2 expert panelists: Tina Tan, MD, a pediatric infectious disease physician and professor of pediatrics at Northwestern University’s Feinberg School of Medicine; and Joanne Nazif, MD ...

The FDA has accepted a new drug application (NDA) for epinephrine sublingual film (Anaphylm; Aquestive Therapeutics) to treat type 1 allergic reactions, including anaphylaxis. With the acceptance of ...

On June 13, 2025, the FDA announced it will not meet the June 17, 2025, target action date to make a decision regarding KalVista Pharmaceuticals' sebetralstat to treat HAE in patients aged 12 years ...

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks. The FDA will not meet a prescription drug user fee act (PDUFA) ...

The approval for ustekinumab-stba now offers all dosage forms to the reference product, ustekinumab, and is indicated for patients aged 6 to 17 years. On June 15, 2025, the FDA announced the approval ...

Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children. Fathers’ diets during their teenage years ...

On June 12, a new phase 3 clinical study of the Vimkunya single-dose, virus-like particle (VLP) chikungunya vaccine was initiated by Bavarian Nordic A/S among children aged 2 to 11 years, according to ...